{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-026238","form_type":"8-K","ticker":"GCTK","cik":"0001506983","company_name":"Glucotrack, Inc.","filed_at":"2021-10-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.794367+00:00","generated_at":"2026-06-28T18:25:38.409312+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Integrity Applications appoints Paul Goode as President and COO effective Nov 1, 2021","bullets":["Paul V. Goode appointed President and COO effective November 1, 2021; steps down from Board.","Base salary of $175,000/year; eligible for cash bonus up to 20% of base salary.","Granted options to purchase 1.5% of fully diluted common stock at exercise price ≥ $5.20, vesting over 3 years.","Goode most recently VP of Product Development at Orchestra Biomed; will lead U.S. infrastructure for GlucoTrack trials.","Employment agreement includes standard termination provisions and financial-misstatement clawback."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-026238","json":"https://secwatch.observer/filing/0001493152-21-026238.json","markdown":"https://secwatch.observer/filing/0001493152-21-026238.md","text":"https://secwatch.observer/filing/0001493152-21-026238.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506983/000149315221026238/0001493152-21-026238-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506983/000149315221026238/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T18:25:38.409312+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"08457f84d2","claim":"Paul V. Goode was appointed as President and Chief Operating Officer at Glucotrack, Inc..","evidence_excerpt":"On October 19, 2021, Paul V. Goode was appointed as President and Chief Operating Officer of Integrity Applications, Inc. (the “Company”), effective November 1, 2021 (“Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1506983/000149315221026238/0001493152-21-026238-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Operating Officer"}],"fact_type":"executive_change"},{"claim_id":"afd165e729","claim":"Paul V. Goode departed as Director at Glucotrack, Inc..","evidence_excerpt":"Concurrent with his new appointment, Mr. Goode will be stepping down from the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1506983/000149315221026238/0001493152-21-026238-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepping down"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}